Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function
NCT02775981
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Analgesic Allergy
Interventions
DRUG:
RX0041-002
Sponsor
Pharmaceutical Project Solutions, Inc.
Collaborators
[object Object]